TC
CORV

TFS Capital’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

TFS Capital’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,620
Closed -$44K – 845
2017
Q1 		$44K Buy
+14,620
New +$43.1K 0.01% 631
2014
Q2 		– Sell
-45,074
Closed -$357K – 1453
2014
Q1 		$357K Buy
45,074
+18,958
+73% +$153K 0.02% 917
2013
Q4 		$163K Sell
26,116
-3,821
-13% -$20K 0.01% 1328
2013
Q3 		$106K Sell
29,937
-14,008
-32% -$31.9K ﹤0.01% 1356
2013
Q2 		$86K Buy
+43,945
New +$88.1K ﹤0.01% 1436

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

TFS Capital's CORV Position: Q2 2017 in Review

TFS Capital sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2017, closing a stake of 14,620 shares — an estimated $44K sold.

TFS Capital first reported a position in CORV in Q2 2013 and held it in 5 quarters. The position peaked at $357K in Q1 2014. 27 funds tracked by Wall St. Rank hold CORV as of Q2 2017.

  • TFS Capital reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2017 after selling out during the quarter.
  • TFS Capital sold 14,620 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2017, an estimated $44K.
  • TFS Capital first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 5 quarters.
  • TFS Capital's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $357K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.